¼¼°èÀÇ ½ÉÀå¹Úµ¿ °ü¸®(CRM) ±â±â ½ÃÀå
Cardiac Rhythm Management (CRM) Devices
»óǰÄÚµå : 1514239
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 274 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,106,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,320,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ½ÉÀå¹Úµ¿ °ü¸®(CRM) ±â±â ½ÃÀåÀº 2030³â±îÁö 239¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»ó

2023³â¿¡ 185¾ï ´Þ·¯·Î Æò°¡µÈ ¼¼°èÀÇ ½ÉÀå¹Úµ¿ °ü¸®(CRM) ±â±â ½ÃÀåÀº ºÐ¼® ±â°£ 2023³âºÎÅÍ 2030³â±îÁö CAGR 3.8%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2030³â¿¡´Â 239¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Á¦¼¼µ¿±â´Â CAGR 4.4%·Î ¼ºÀåÀ» Áö¼ÓÇϰí, ºÐ¼® ±â°£ Á¾·á ½Ã 113¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ÉÀå¹Úµ¿±â ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 3.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 50¾ï ´Þ·¯, Áß±¹Àº CAGR 6.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ½ÉÀå¹Úµ¿ °ü¸®(CRM) ±â±â ½ÃÀåÀº 2023³â 50¾ï ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 50¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ 2023³âºÎÅÍ 2030³â±îÁö CAGRÀº 6.6%·Î Àü¸ÁµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 0.9%¿Í 4.4%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 1.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ½ÉÀå¹Úµ¿ °ü¸®(CRM) ±â±â ½ÃÀå-ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

½ÉÀå¹Úµ¿ °ü¸®(CRM) ±â±â´Â ºÒ±ÔÄ¢ÇÑ ½É¹Ú ¸®µë ¹× ±âŸ °ü·Ã ½ÉÀå ÁúȯÀÇ Áø´Ü ¹× Ä¡·á¸¦ À§ÇØ ÀÇ·á ºÐ¾ß¿¡¼­ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡¿¡´Â ½É¹ÚÁ¶À²±â, À̽ÄÇü Á¦¼¼µ¿±â(ICD), ½ÉÀå À絿±â ¿ä¹ý(CRT) ÀåÄ¡ µî ÀûÀýÇÑ ½ÉÀå ±â´ÉÀ» º¸ÀåÇϵµ·Ï ¼³°èµÈ ´Ù¾çÇÑ Á¦Ç°ÀÌ Æ÷ÇԵ˴ϴÙ. ½É¹Ú Á¶À²±â´Â ÁÖ·Î ÀÏÁ¤ÇÑ ½ÉÀå ¹Úµ¿À» ÀÚ±ØÇÏ´Â Àü±â ÀÓÆÞ½º¸¦ º¸³» ¼­¸ÆÀ» °ü¸®ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ÇÑÆí, ICD´Â ½ÉÀåÀÇ ¸®µëÀ» Áö¼ÓÀûÀ¸·Î °¨½ÃÇÏ°í ½ÉÇÑ ºÎÁ¤¸ÆÀ̳ª °©ÀÛ½º·± ½ÉÁ¤ÁöÀÇ ¿¡ÇǼҵå Áß¿¡ ±¸¸íÀ» À§ÇÑ Ãæ°ÝÀ» ÁÖ¾î Á¤»óÀûÀÎ ¸®µëÀ» ȸº¹½Ãŵ´Ï´Ù. CRT´Â ½É½Ç ¼öÃàÀ» Á¶Á¤ÇÏ°í °¢ ½ÉÀå ¹Úµ¿ÀÇ È¿À²À» Çâ»ó½Ã۱⠶§¹®¿¡ ½ÉºÎÀü ȯÀÚ¿¡°Ô ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. CRM ±â±â¿¡¼­´Â ¸®µå¼±(ħ±Ý)À» ÇÊ¿ä·Î ÇÏÁö ¾Ê°í °¨¿° ¸®½ºÅ©¿Í ¼ö¼ú ÇÕº´ÁõÀ» °æ°¨ÇÏ´Â ¸®µå¸®½º ÆäÀ̽º¸ÞÀÌÄ¿ÀÇ °³¹ß µî ´ëÆøÀûÀÎ ±â¼ú Áøº¸¸¦ º¼ ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡ MRI¿¡ ´ëÀÀÇÑ CRM ÀåÄ¡µµ µîÀåÇØ, Á¾·¡´Â ±Ý±â·Î µÇ¾î ÀÖ´ø Àڱ⠰ø¸í À̹Ì¡À» ¾ÈÀüÇÏ°Ô ¹ÞÀ» ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

CRM ±â±â ½ÃÀåÀº ½ÉÇ÷°üÁúȯÀÇ À¯º´·ü »ó½Â°ú Áøº¸µÈ Áø´Ü ¹× Ä¡·á ±â¼úÀÇ Ã¤¿ë Áõ°¡¿¡ ÀÇÇØ Å« ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ½ÉÇ÷°ü ÁúȯÀº ¿©ÀüÈ÷ ¼¼°è »ç¸ÁÀÇ ÁÖ¿ä ¿øÀÎ Áß ÇϳªÀÌ¸ç ¼ö¹é¸¸ ¸íÀÇ »ç¶÷µé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¡°í È¿°úÀûÀÎ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ Å« ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ½ÉÀå ÁúȯÀ» ¾Î°í ÀÖ´Â ¼¼°è Àα¸ÀÇ ³ë·ÉÈ­´Â CRM ÀåºñÀÇ Çʿ伺À» ´õ¿í ³ô¿©ÁÝ´Ï´Ù. ¶ÇÇÑ CRM Àåºñ¿¡ ¿ø°Ý ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀ» ÅëÇÕÇÏ¸é ½ÉÀå ¸®µëÀÇ Áö¼ÓÀûÀÎ ½Ç½Ã°£ ¸ð´ÏÅ͸µÀÌ °¡´ÉÇϰí Àû½Ã¿¡ ÀÇ·á °³ÀÔÀÌ ½¬¿öÁö°í ȯÀÚ Äɾ Çõ¸íÀûÀÎ º¯È­°¡ »ý±é´Ï´Ù. ÀÌ·¯ÇÑ ¿ø°Ý ½Ã½ºÅÛÀº ÀáÀçÀûÀÎ ¹®Á¦¸¦ Á¶±â¿¡ ¹ß°ßÇÔÀ¸·Î½á ȯÀÚÀÇ ¿¹Èĸ¦ °³¼± ÇÒ»Ó¸¸ ¾Æ´Ï¶ó ºó¹øÇÑ Åë¿ø ¹× ÀçÀÔ¿øÀÇ Çʿ伺À» ÁÙÀÌ°í °á±¹ ÀÇ·áºñ¸¦ ÁÙÀÔ´Ï´Ù. ÇコÄɾî Á¦°ø¾÷ü´Â ÄɾîÀÇ ÁúÀ» ³ôÀ̱â À§ÇØ ÀÌ·¯ÇÑ °í±Þ CRM Àåºñ¸¦ äÅÃÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¼±Áø±¹ ½ÃÀå°ú ½ÅÈï±¹ ½ÃÀå ¸ðµÎ¿¡¼­ À¯¸®ÇÑ »óȯ Á¤Ã¥°ú ÀÇ·áºñ Áõ°¡´Â ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼­ CRM ÀåºñÀÇ Ã¤ÅÃÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

CRM ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ±â¼úÀÇ Áøº¸, ½ÉÇ÷°ü ÁúȯÀÇ ÀÌȯÀ² Áõ°¡, Àúħ½À óġ¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ¹«¼± CRM ±â±â¿Í ÀΰøÁö´É ÅëÇÕ µîÀÇ ±â¼ú Çõ½ÅÀ¸·Î CRM ±â±âÀÇ ±â´É¼º°ú ȯÀÚ ÆíÀǼºÀÌ Å©°Ô Çâ»óµÇ¾î ä¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¸®µå·¹½ºÆäÀ̽º¸ÞÀÌÄ¿³ª MRI ´ëÀÀ ±â±â ½ÃÀå °³Ã´Àº ȯÀÚ¿¡ ÀÇÇØ ¾ÈÀüÇÏ°í ´ÙÀç´Ù´ÉÇÑ ¿É¼ÇÀ» Á¦°øÇÔÀ¸·Î½á ´ëÀÀ °¡´ÉÇÑ ½ÃÀåÀ» È®´ëÇß½À´Ï´Ù. ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ³ëÈ­·Î ÀÎÇØ È¿°úÀûÀÎ °ü¸® µµ±¸·Î¼­ CRM ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¿Ü·¡ óġ¿Í ÀçÅà ÄÉ¾î ¸ðµ¨·ÎÀÇ À̵¿Àº ÈÞ´ë¿ë ¿ø°Ý ¸ð´ÏÅ͸µÀÌ °¡´ÉÇÑ CRM ±â±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀΰú ±âÁØÀº ÀÌ·¯ÇÑ ÀåºñÀÇ ¾ÈÀü¼º°ú È¿´ÉÀ» º¸ÀåÇÏ¸ç ½ÃÀå µµÀÔ ÃßÁø¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. °Ô´Ù°¡ ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ÇコÄɾî ÀÎÇÁ¶óÀÇ È®´ë³ª ½ÉÀåÄÉ¾î ½Ã¼³¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡´Â ÷´Ü CRM ±â¼úÀ» º¸´Ù Æø³ÐÀº ȯÀÚÃþÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô ÇØ »õ·Î¿î ¼ºÀå ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. Çõ½ÅÀûÀ̰í È¿°úÀûÀÎ ½ÉÀå °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ Çʿ伺 Áõ°¡¸¦ ¹Ý¿µÇÏ¿© CRM Àåºñ ½ÃÀåÀÇ °ßÁ¶ÇÑ ¼ºÀå ±Ëµµ¸¦ µÞ¹ÞħÇÕ´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 34°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cardiac Rhythm Management (CRM) Devices Market to Reach US$23.9 Billion by 2030

The global market for Cardiac Rhythm Management (CRM) Devices estimated at US$18.5 Billion in the year 2023, is expected to reach US$23.9 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Defibrillators, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$11.3 Billion by the end of the analysis period. Growth in the Pacemakers segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.0 Billion While China is Forecast to Grow at 6.6% CAGR

The Cardiac Rhythm Management (CRM) Devices market in the U.S. is estimated at US$5.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.0 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Cardiac Rhythm Management (CRM) Devices Market - Key Trends and Drivers Summarized

Cardiac Rhythm Management (CRM) devices are crucial in the medical field for diagnosing and treating irregular heart rhythms and other related cardiac conditions. These devices include a diverse array of products such as pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices, all designed to ensure proper heart function. Pacemakers are primarily used to manage bradycardia by sending electrical impulses to stimulate a consistent heartbeat. ICDs, on the other hand, continuously monitor heart rhythms and deliver life-saving shocks to restore normal rhythm during episodes of severe arrhythmias or sudden cardiac arrest. CRT devices are particularly beneficial for patients with heart failure, as they coordinate the contractions of the heart's ventricles, improving the efficiency of each heartbeat. The CRM device landscape has seen substantial technological advancements, such as the development of leadless pacemakers, which eliminate the need for leads (wires) and thereby reduce infection risks and procedural complications. Additionally, MRI-compatible CRM devices have emerged, allowing patients with these implants to safely undergo magnetic resonance imaging, which was previously contraindicated.

The market for CRM devices is experiencing significant growth driven by the rising prevalence of cardiovascular diseases and the increasing adoption of advanced diagnostic and therapeutic technologies. Cardiovascular diseases remain one of the leading causes of mortality worldwide, affecting millions of people and creating a substantial demand for effective management solutions. The aging global population, which is more susceptible to cardiac conditions, further drives the need for CRM devices. Moreover, the integration of remote monitoring systems in CRM devices has revolutionized patient care by enabling continuous, real-time monitoring of heart rhythms, thereby facilitating timely medical interventions. These remote systems not only improve patient outcomes by providing early detection of potential issues but also reduce the need for frequent hospital visits and readmissions, ultimately lowering healthcare costs. Healthcare providers are increasingly adopting these advanced CRM devices to enhance the quality of care. Additionally, favorable reimbursement policies and growing healthcare expenditure in both developed and emerging markets are bolstering the adoption of CRM devices across various healthcare settings.

The growth in the CRM devices market is driven by several factors, including technological advancements, the rising incidence of cardiovascular diseases, and the growing preference for minimally invasive procedures. Technological innovations, such as wireless CRM devices and the integration of artificial intelligence, have significantly enhanced the functionality and patient-friendliness of these devices, leading to increased adoption. The development of leadless pacemakers and MRI-compatible devices has expanded the addressable market by offering safer and more versatile options for patients. The increasing prevalence of cardiovascular diseases, coupled with an aging population, has heightened the demand for CRM devices as effective management tools. Moreover, the shift towards outpatient procedures and home-based care models has driven the demand for portable and remotely monitored CRM devices. Regulatory approvals and standards have also played a crucial role in propelling market adoption, ensuring the safety and efficacy of these devices. Furthermore, the expansion of healthcare infrastructure in emerging markets and rising investments in cardiac care facilities have generated new growth opportunities, making advanced CRM technologies more accessible to a broader patient population. These factors collectively underscore the robust growth trajectory of the CRM devices market, reflecting the increasing need for innovative and effective cardiac care solutions.

Select Competitors (Total 34 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â